HIV has become one of the most devastating pathogens in human history. Despite fast progress in HIV-related basic research, antiretroviral therapy (ART) remains the most effective method to save AIDS patients' lives. Unfortunately, ART cannot be universally accessed, especially in developing countries, due to the lack of effective treatment monitoring diagnostics. Here, we present an inexpensive, rapid and portable micro-a-fluidic platform, which can streamline the process of an enzyme-linked immunosorbent assay (ELISA) in a fully automated manner for CD4 cell count. The micro-a-fluidic CD4 cell count is achieved by eliminating operational fluid flow via “moving the substrate”, as opposed to “flowing liquid” in traditional ELISA or microflu...
HIV has caused a global pandemic over the last three decades. There is an unmet need to develop poin...
AbstractInfectious diseases remain a major health concern in many parts of the developing world, whe...
In recent years, microfluidic lab-on-a-chip devices have made tremendous progress. Many new features...
HIV has become one of the most devastating pathogens in human history. Despite fast progress in HIV-...
HIV has become one of the most devastating pathogens in human history. Despite fast progress in HIV-...
Background: More than 35 million people in developing countries are living with HIV infection. An en...
With timely diagnosis and correct treatment, people living with HIV/AIDS can consider the disease as...
We demonstrate an integrated platform that merges a microfluidic chip with lensless imaging to targe...
We demonstrate the fabrication of fully printed microfluidic CD4 counting chips with complete on-chi...
The most recent guidelines have called for a significant shift towards viral load testing for HIV/AI...
The HIV/AIDS pandemic has killed 39 million people worldwide, and nearly as many people are living w...
T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected patients during an...
We present a simple system for CD4 and CD8 counting for point-of-care HIV staging in low-resource se...
clinical utility. device'sresource-limited settings. Nevertheless, more testing on patients ove...
HIV has caused a global pandemic over the last three decades. There is an unmet need to develop poin...
AbstractInfectious diseases remain a major health concern in many parts of the developing world, whe...
In recent years, microfluidic lab-on-a-chip devices have made tremendous progress. Many new features...
HIV has become one of the most devastating pathogens in human history. Despite fast progress in HIV-...
HIV has become one of the most devastating pathogens in human history. Despite fast progress in HIV-...
Background: More than 35 million people in developing countries are living with HIV infection. An en...
With timely diagnosis and correct treatment, people living with HIV/AIDS can consider the disease as...
We demonstrate an integrated platform that merges a microfluidic chip with lensless imaging to targe...
We demonstrate the fabrication of fully printed microfluidic CD4 counting chips with complete on-chi...
The most recent guidelines have called for a significant shift towards viral load testing for HIV/AI...
The HIV/AIDS pandemic has killed 39 million people worldwide, and nearly as many people are living w...
T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected patients during an...
We present a simple system for CD4 and CD8 counting for point-of-care HIV staging in low-resource se...
clinical utility. device'sresource-limited settings. Nevertheless, more testing on patients ove...
HIV has caused a global pandemic over the last three decades. There is an unmet need to develop poin...
AbstractInfectious diseases remain a major health concern in many parts of the developing world, whe...
In recent years, microfluidic lab-on-a-chip devices have made tremendous progress. Many new features...